Beta-thalassemia future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 8: | Line 8: | ||
<ref name="pmid30700149">{{cite journal |vauthors=Coquerelle S, Ghardallou M, Rais S, Taupin P, Touzot F, Boquet L, Blanche S, Benaouadi S, Brice T, Tuchmann-Durand C, Ribeil JA, Magrin E, Lissillour E, Rochaix L, Cavazzana M, Durand-Zaleski I |title=Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation |journal=Hum Gene Ther |volume=30 |issue=6 |pages=753–761 |date=June 2019 |pmid=30700149 |doi=10.1089/hum.2018.178 |url=}}</ref> | <ref name="pmid30700149">{{cite journal |vauthors=Coquerelle S, Ghardallou M, Rais S, Taupin P, Touzot F, Boquet L, Blanche S, Benaouadi S, Brice T, Tuchmann-Durand C, Ribeil JA, Magrin E, Lissillour E, Rochaix L, Cavazzana M, Durand-Zaleski I |title=Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation |journal=Hum Gene Ther |volume=30 |issue=6 |pages=753–761 |date=June 2019 |pmid=30700149 |doi=10.1089/hum.2018.178 |url=}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 22:14, 21 August 2023
Beta-thalassemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Beta-thalassemia future or investigational therapies On the Web |
American Roentgen Ray Society Images of Beta-thalassemia future or investigational therapies |
Beta-thalassemia future or investigational therapies in the news |
Blogs on Beta-thalassemia future or investigational therapies |
Risk calculators and risk factors for Beta-thalassemia future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]
Overview
Future or investigational therapies
References
- ↑ Coquerelle S, Ghardallou M, Rais S, Taupin P, Touzot F, Boquet L, Blanche S, Benaouadi S, Brice T, Tuchmann-Durand C, Ribeil JA, Magrin E, Lissillour E, Rochaix L, Cavazzana M, Durand-Zaleski I (June 2019). "Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation". Hum Gene Ther. 30 (6): 753–761. doi:10.1089/hum.2018.178. PMID 30700149.